PARP1 and cancer: By preventing DNA recovery by BER, PARP inhibitors lead to enhanced susceptibility to cytotoxic chemotherapy or, in the best cases, PARP inhibition itself could induce cell death in those cancers defective for HR mechanism10–12, 27, 28.